¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"mixed lymphocyte response"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
sensitized lymphocyte
¹Î°¨È¸²ÇÁ±¸
mixed acid
È¥ÇÕ»ê
mixed aphasia
È¥ÇÕ¾ð¾î»ó½ÇÁõ, È¥ÇսǾîÁõ
mixed astigmatism
È¥ÇÕ³½Ã
mixed beam irradiation
È¥ÇÕºû»ìÁ¶»ç, È¥ÇÕºöÁ¶»ç
mixed cellular cast
È¥ÇÕ¼¼Æ÷¿øÁÖ
mixed chancre
È¥Çձ˾ç
mixed connective tissue disease
È¥ÇÕ°áÇÕÁ¶Á÷º´
mixed cryoglobulinemia
È¥ÇÕÇÑ·©±Û·ÎºÒ¸°Ç÷Áõ, È¥ÇÕÀú¿Â±Û·ÎºÒ¸°Ç÷Áõ
mixed culture
¼¯¾î½É±â, È¥ÇÕ¹è¾ç
mixed density
1. È¥Çչеµ 2. È¥ÇÕÀ½¿µ
mixed episode
È¥Àç»ðÈ
mixed gallstone
È¥ÇÕ¾µ°³µ¹, È¥ÇÕ´ã¼®
mixed germ cell tumor
È¥ÇÕÁ¾ÀÚ¼¼Æ÷Á¾¾ç
mixed gland
È¥ÇÕ»ù, È¥ÇÕ¼±
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
short lived lymphocyte
´Ü»ý¸²ÇÁ±¸, ªÀº¼ö¸í¸²ÇÁ±¸
thymic lymphocyte
°¡½¿»ù¸²ÇÁ±¸
thymus-derived lymphocyte
°¡½¿»ùÀ¯·¡¸²ÇÁ±¸
monocyte lymphocyte ratio
´ÜÇÙ±¸¸²ÇÁ±¸ºñÀ²
primed lymphocyte typing
ÃÊȸÇ׿øÀÚ±ØÈĸ²ÇÁ±¸Çüº°È
primed lymphocyte-typing test
°¨ÀÛ¸²ÇÁ±¸Çüº°°Ë»ç
mixed acid
È¥ÇÕ»ê
mixed amputation
È¥ÇÕÀý´Ü
mixed aphasia
(¢¡global aphasia) ¿ÏÀü¾ð¾î»ó½ÇÁõ
mixed astigmatism
È¥ÇÕ³½Ã
mixed chancre
È¥Çձ˾ç
mixed cryoglobulinemia
È¥ÇÕÇÑ·©±Û·ÎºÒ¸°Ç÷Áõ
mixed culture
¼¯¾î½É±â
mixed cellular cast
È¥ÇÕ¼¼Æ÷¿øÁÖ
mixed decimal
´ë¼Ò¼ö
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
anti-lymphocyte globulin
¸²ÇÁ±¸ Çױ۷κҸ°
antigen, lymphocyte defined (LD)
¸²ÇÁ±¸ Ç¥¸éÇ׿ø, LDÇ׿ø
granulocyte-monocyte-lymphocyte antigens
°ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
granulocyte-platelet-lymphocyte antigens
°ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
hodgkins disease,lymphocyte predominance
¸²ÇÁ±¸ ÇöÀúÇü
primed lymphocyte
ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸
primed lymphocyte typing
ÃÊȸÇ׿øÀÚ±ØÈÄ ¸²ÇÁ±¸Çüº°È
primed lymphocyte-typing test
ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸ÀÌ¿ë Çüº°°Ë»ç
BERA =Brainstem Evoked Response Audiometry
³ú°£À¯¹ß¹ÝÀÀû·Â°Ë»ç
Fast response
±Þ¼Ó(ÐááÜ)¹ÝÀÀ(Úãëë)
Inflammatory response
¿°Áõ¹ÝÀÀ(æúñøÚãëë)
Lewis triple response
·çÀ̽º »ïÁß ¹ÝÀÀ
MAC-BAR(minimum alveolar concentration-blockade of autonomic response)
ÀÚÀ²½Å°æ¾ïÁ¦ ÃÖ¼ÒÆóÆ÷³»³óµµ
allergic response
¾Ë·¹¸£±â¹ÝÀÀ, °ú¹Î¹ÝÀÀ
analytical response detection
ºÐ¼®¹ÝÀÀ°¨Áö
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
large lymphocyte
´ë¸²ÇÁ±¸(¡Ï¹).
large lymphocyte
Å«¸²ÇÁ±¸
large lymphocyte
´ë¸²ÇÁ±¸(?Ë´).
leukocytoid lymphocyte
¹éÇ÷±¸¾ç ¸²ÇÁ±¸
lymphocyte
¸²ÇÁ±¸(¡Ï¹).
lymphocyte
¸²ÇÁ±¸
lymphocyte activating factor
¸²ÇÁ±¸È°¼ºÀÎÀÚ
lymphocyte activating factor (LAF)
¸²ÇÁ±¸ Ȱ¼ºÈÀÎÀÚ
lymphocyte analysis
¸²ÇÁ±¸ºÐ¼®
lymphocyte defined antigen
¸²ÇÁ±¸±ÔÁ¤Ç׿ø.
lymphocyte development
¸²ÇÁ±¸¹ßÀ°
lymphocyte dysfunction
¸²ÇÁ±¸±â´ÉÀå¾Ö<--ºÎÀü>
lymphocyte inhibitory factor (LIF)
¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
lymphocyte interaction
¸²ÇÁ±¸»óÈ£ÀÛ¿ë.
lymphocyte microcytotoxicity assay
¸²ÇÁ±¸¼Ò¼¼Æ÷µ¶¼º°Ë»ç
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½